Research ArticleOriginal Article

Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial

Junjie Li, Jingyi Cheng, Guangyu Liu, Yifeng Hou, Genghong Di, Benglong Yang, Yizhou Jiang, Liang Huang, Feilin Qu, Sheng Chen, Yan Wang, Keda Yu and Zhimin Shao
Cancer Biology & Medicine July 2022, 19 (7) 1100-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0085

Article Information

vol. 19 no. 7 1100-1108
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2022.0085
Published By 
Cancer Biology & Medicine
History 
  • Received February 25, 2022
  • Accepted April 12, 2022
  • Published online July 27, 2022.
Copyright & Usage 
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Junjie Li1,2,*,
  2. Jingyi Cheng3,*,
  3. Guangyu Liu1,2,
  4. Yifeng Hou1,2,
  5. Genghong Di1,2,
  6. Benglong Yang1,2,
  7. Yizhou Jiang1,2,
  8. Liang Huang1,2,
  9. Feilin Qu1,2,
  10. Sheng Chen1,2,
  11. Yan Wang1,2,
  12. Keda Yu1,2 and
  13. Zhimin Shao1,2⇑
  1. 1Department of Breast Surgery, Fudan University Shanghai Cancer Center, and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  2. 2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200032, China
  3. 3Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  1. Correspondence to: Zhimin Shao E-mail: zhimingshao{at}yahoo.com
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords